Supreme Court blocks lower court ruling, keeps mail-order access to abortion pill mifepristone

The Supreme Court issued an indefinite stay that preserves mail-order access to the abortion medication mifepristone. The order maintains the ability for providers to prescribe the drug through pharmacies or by mail without requiring an in‑person visit while the related lawsuit proceeds.

The stay follows an emergency petition filed by drugmakers Danco Laboratories and GenBioPro after a lower court had cut off mail‑order distribution of the pill. The petition asked the high court to halt the lower court’s decision, which had been issued only weeks earlier.

Justices Clarence Thomas and Samuel Alito dissented, arguing that the order undermines the Court’s earlier decision to overturn Roe v. Wade. The Supreme Court did not provide a detailed explanation for its emergency order, and the broader legal battle over mifepristone access continues.